Neuron23
Changing the future of Parkinson's disease.
South San Francisco, United States · Founded 2018 · $310.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- neuron23.com
- Total Funding
- $310.0M
- Last Round
- $96.5M Series DJun 2025
- Rounds
- 4
About
Neuron23 is a clinical-stage biotechnology company combining human genetics and data science to develop precision medicines for Parkinson's disease. Its lead program targets LRRK2, a genetic driver of Parkinson's, using machine learning and functional genomics to identify and match patients to therapies. The company was founded in 2018 by a team of drug hunters, geneticists, and neuroscientists.
Summary
Neuron23 is a Biotech company based in South San Francisco, United States, founded in 2018. It has raised $310.0M in total across 4 rounds, most recently a $96.5M Series D round in Jun 2025. Investors include Westlake Village BioPartners, Blue Owl Capital and SoftBank.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jun 2025
Sign up to see all 4 rounds
Series A through Series D — per-round amounts, valuations, and who invested in each round.
Investors
.png)
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/neuron23"><img src="https://indexed.vc/api/badge/company/neuron23" alt="Neuron23 on Indexed.vc" width="260" height="76" /></a>